Skip to main content

Advertisement

Log in

δ-Catenin promotes the malignant phenotype in breast cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

δ-Catenin is a member of the p120 catenin family. Similar to p120ctn, δ-catenin contains nine central Armadillo repeats and binds to the juxtamembrane domain (JMD) of E-cadherin. We used immunohistochemistry to detect δ-catenin expression in breast carcinoma (128 cases), and δ-catenin mRNA and protein expression was detected by reverse transcription-polymerase chain reaction and Western blotting (45 cases). The effects of δ-catenin on the activity of small GTPases and the biological behavior of breast cancer cells were explored by pulldown, flow cytometry, methyl thiazolyl tetrazolium, and Matrigel invasion assays. The results showed that δ-catenin expression increased in breast cancer tissues and was associated with a higher degree of malignancy (invasive lobular breast cancer, high tumor-node-metastasis stage, lymph node metastasis, and C-erbB-2+) and poor prognosis. Postoperative survival was shorter in patients with δ-catenin-positive expression than in patients with negative expression. δ-Catenin may regulate Cdc42/Rac1 activity, promote proliferation and invasion of breast cancer cells, and alter cell cycle progression. We conclude that δ-catenin tends to overexpress in breast carcinoma and promotes the malignant phenotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Matter C, Pribadi M, Liu X, Trachtenberg JT. Delta-catenin is required for the maintenance of neural structure and function in mature cortex in vivo. Neuron. 2009;64(3):320–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. De Busk LM, Boelte K, Min Y, Lin PC. Heterozygous deficiency of delta-catenin impairs pathological angiogenesis. J Exp Med. 2010;207(1):77–84.

    Article  Google Scholar 

  3. Gu D, Tonthat NK, Lee M, Ji H, Bhat KP, Hollingsworth F, et al. Caspase-3 cleavage links delta-catenin to the novel nuclear protein ZIFCAT. J Biol Chem. 2011;286(26):23178–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Zhang H, Dai SD, Zhang D, Liu D, Zhang FY, Zheng TY, et al. Delta-catenin promotes the proliferation and invasion of colorectal cancer cells by binding to E-cadherin in a competitive manner with p120 catenin. Target Oncol. 2014;9(1):53–61.

    Article  PubMed  Google Scholar 

  5. Brigidi GS, Sun Y, Beccano-Kelly D, Pitman K, Mobasser M, Borgland SL, et al. Palmitoylation of δ-catenin by DHHC5 mediates activity-induced synapse plasticity. Nat Neurosci. 2014;17(4):522–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kim H, He Y, Yang I, Zeng Y, Kim Y, Seo YW, et al. δ-Catenin promotes E-cadherin processing and activates β-catenin-mediated signaling: implications on human prostate cancer progression. Biochim Biophys Acta. 2012;1822(4):509–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhang JY, Wang Y, Zhang D, Yang ZQ, Dong XJ, Jiang GY, et al. delta-catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm. J Pathol. 2010;222(1):76–88.

    CAS  PubMed  Google Scholar 

  8. Lu Q, Lanford GW, Hong H, Chen YH. δ-Catenin as a potential cancer biomarker. Pathol Int. 2014;64(5):243–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lu JP, Zhang J, Kim K, Case TC, Matusik RJ, Chen YH, et al. Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer. Mol Cancer. 2010;9:304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wang M, Dong Q, Zhang D, Wang Y. Expression of delta-catenin is associated with progression of human astrocytoma. BMC Cancer. 2011;11:514.

    Article  CAS  PubMed  Google Scholar 

  11. Hatzfeld M. The p120 family of cell adhesion molecules. Eur J Cell Biol. 2005;84:205–14.

    Article  CAS  PubMed  Google Scholar 

  12. Burger MJ, Tebay MA, Keith PA, Samaratunga HM, Clements J, Lavin MF, et al. Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer. Int J Cancer. 2002;100(2):228–37.

    Article  CAS  PubMed  Google Scholar 

  13. Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, Shappell S, et al. Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer. Hum Pathol. 2005;36(10):1037–48.

    Article  CAS  PubMed  Google Scholar 

  14. Arikkath J, Peng IF, Ng YG, Israely I, Liu X, Ullian EM, et al. Delta-catenin regulates spine and synapse morphogenesis and function in hippocampal neurons during development. J Neurosci. 2009;29(17):5435–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kawamura Y, Fan QW, Hayashi H, Michikawa M, Yanagisawa K, Komano H. Expression of the mRNA for two isoforms of neural plakophilin-related arm-repeat protein/delta-catenin in rodent neurons and glial cells. Neurosci Lett. 1999;277:185–8.

    Article  CAS  PubMed  Google Scholar 

  16. Lu Q, Paredes M, Medina M, et al. delta-catenin, an adhesive junction associated protein which promotes cell scattering. J Cell Biol. 1999;144:519–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhang JY, Zhang D, Wang EH. Overexpression of small GTPases directly correlates with expression of δ-catenin and their coexpression predicts a poor clinical outcome in nonsmall cell lung cancer. Mol Carcinog. 2013;52(5):338–47.

    Article  CAS  PubMed  Google Scholar 

  18. Lane J, Martin T, Weeks HP, Jiang WG. Structure and role of WASP and WAVE in Rho GTPase signalling in cancer. Cancer Genomics Proteomics. 2014;11(3):155–65.

    PubMed  Google Scholar 

  19. Zins K, Lucas T, Reichl P, Abraham D, Aharinejad S. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice. PLoS One. 2013;8(9):e74924. doi:10.1371/journal.pone.0074924. eCollection 2013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dai SD, Wang Y, Zhang JY, Zhang D, Zhang PX, Jiang GY, et al. Upregulation of δ-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer. Cancer Sci. 2011;102(1):95–103.

    Article  CAS  PubMed  Google Scholar 

  21. Nopparat J, Zhang J, Lu JP, Chen YH, Zheng D, Neufer PD, et al. δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming. Oncogene. 2014 Apr 14;0.

Download references

Acknowledgments

We sincerely thank Dr. Shun-ichi Nakamura at Kobe University, Japan, for kindly providing pCMV5-FLAG/δ-catenin. This work was supported by the National Natural Science Foundation of China (no. 81101779 to Di Zhang, MD; no. 30870977 and 81071905 to En-Hua Wang, MD; no. 81201844 to Jun-Yi Zhang, MD; no. 81372338 to Shu-Li Liu).

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to En-Hua Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, D., Zhang, JY. & Wang, EH. δ-Catenin promotes the malignant phenotype in breast cancer. Tumor Biol. 36, 569–575 (2015). https://doi.org/10.1007/s13277-014-2680-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2680-8

Keywords

Navigation